← back to search

David Liebowitz

Vaxart (United States) · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, Influenza Virus Research Studies, and CAR-T cell therapy research.
h-index
17
citations
2,868
works
42
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3).
Journal of Clinical Oncology 2022cited by 11position: lastdoi
Safety and Anti-Tumor Activity of Plamotamab (XmAb13676), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Subjects with Relapsed/Refractory Non-Hodgkin's Lymphoma
Blood 2021cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2021–2022)Ezra E.W. Cohen · University of Michigan1 papers (2022–2022)Hervé Tilly · Normandie Université1 papers (2021–2021)Melhem Solh · University College London1 papers (2021–2021)Breelyn A. Wilky · University of Colorado Cancer Center1 papers (2022–2022)Asher Chanan‐Khan · WinnMed1 papers (2021–2021)Jennifer H. Choe · Vanderbilt-Ingram Cancer Center1 papers (2022–2022)Craig A. Portell · MACOM (United States)1 papers (2021–2021)Gabriel Brisou · Université Claude Bernard Lyon 11 papers (2021–2021)Jennifer M. Specht · University of Washington1 papers (2022–2022)— · 1 papers (2022–2022)— · 1 papers (2022–2022)Diwakar Davar · UPMC Hillman Cancer Center1 papers (2022–2022)Guillaume Cartron · Centre National de la Recherche Scientifique1 papers (2021–2021)Vincent Ribrag · Institut Gustave Roussy1 papers (2021–2021)Krish Patel · Swedish Medical Center1 papers (2021–2021)— · 1 papers (2022–2022)— · 1 papers (2021–2021)Siwen Hu‐Lieskovan · University of Utah Health Care1 papers (2022–2022)Tycel Phillips · Michigan Cancer Research Consortium1 papers (2021–2021)